Literature DB >> 3560939

Radioimmunoassay of plasma progesterone after oral administration of micronized progesterone.

K Nahoul, L Dehennin, R Scholler.   

Abstract

A 200 mg dose of micronized progesterone (P) was administered orally to six healthy volunteers. Serial blood samples were collected and plasma P was assayed according to three methods of different specificity. The results were compared to those obtained with a reference technique based on gas chromatography-mass spectrometry. The interference of P metabolites particularly 5 alpha- and 5 beta-dihydroprogesterone was shown to be important when no or inadequate chromatography was included in the method. Radioimmunoassay after chromatography on a Celite column yielded results similar to those of the reference method. After oral administration, plasma P reached a peak at 3.00 +/- 0.44 h (mean +/- SEM; range: 1-4 h). The mean peak level 4.70 +/- 1.15 ng/ml (mean +/- SEM; range: 2.40-10.10 ng/ml) was at the lower limit of the range defined for a normal functional corpus luteum. The levels returned to initial values by 24 h after the single oral dose. The separation of P from its metabolites by an adequate chromatographic system appears mandatory after oral administration of micronized P.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3560939     DOI: 10.1016/0022-4731(87)90078-1

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  3 in total

1.  Bioequivalence of progesterone sustained release suppository in rabbits.

Authors:  Lihong Long; Qun Huang; Minghui Wu; Shuxian Hou; Zongshun Dai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 2.  Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.

Authors:  Shannon D Sullivan; Philip M Sarrel; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2016-12       Impact factor: 7.329

Review 3.  Hormone Immunoassay Interference: A 2021 Update.

Authors:  Khaldoun Ghazal; Severine Brabant; Dominique Prie; Marie-Liesse Piketty
Journal:  Ann Lab Med       Date:  2022-01-01       Impact factor: 3.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.